06 Feb, 2019 09:12 AM
- Interim (12-week) DARRT-1 readout
- Combination Veyonda + low-dose radiotherapy well tolerated
- PSA, pain and tumour responses at higher doses
- 24-week readout to indicate longevity of re...read more
04 Feb, 2019 09:49 AM
Mediwell Enterprise Pte. Ltd (Mediwell) appointed as distribution partner for Singapore.
Singapore has a fast-growing market for in-vitro diagnostic (IVD) tests.
Melbourne, Australia, 04 Feb 2...read more
22 Jan, 2019 11:14 AM
Mirax Corporation appointed as exclusive distributor for Korea
Important expansion of commercial opportunity in high-growth Asian IVD market
Melbourne, Australia, 22 January 2019: Sienna Cance...read more
14 Jan, 2019 09:49 AM
Lu-PIN-1 Study two-thirds enrolled
Study testing ability of Veyonda to boost effect of Novartis experimental drug
Noxopharm to initiate LuPIN-2 study.
SYDNEY, January 14, 2019: Noxopharm (...read more
08 Jan, 2019 03:07 AM
- President of City of Hope National Medical Center and holds the Deana and Steve Campbell Physician-in-Chief.
- Elected President of the American Association for Cancer Research (AACR) in 2017, th...read more
21 Dec, 2018 08:53 AM
Sydney, Australia - Immutep Limited (ASX:IMM; NASDAQ:IMMP) (“Immutep“ or “the Company“) On 19 December 2018, the Company announced that it had entered into a securities purchas...read more